Research Solutions (RSSS) 10-Q 15 May 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Mar. 31, 2014	7-May-14
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'RSSS	'
Entity Common Stock, Shares Outstanding	'	17,564,164
Entity Registrant Name	'Research Solutions, Inc.	'
Entity Central Index Key	'0001386301	'
Current Fiscal Year End Date	'--06-30	'
Entity Filer Category	'Smaller Reporting Company	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Jun. 30, 2013
Current assets:	'	'
Cash and cash equivalents	$1,648,502	$1,699,969
Accounts receivable:	'	'
Trade receivables, net of allowance of $226,425 and $211,743, respectively	5,385,322	4,966,717
Due from factor	0	165,971
Inventory	103,119	171,682
Prepaid expenses and other current assets	488,814	327,532
Prepaid royalties	554,012	351,852
Total current assets	8,179,769	7,683,723
Other assets:	'	'
Property and equipment, net of accumulated depreciation of $1,418,441 and $1,094,953, respectively	613,293	831,231
Intangible assets, net of accumulated amortization of $390,086 and $308,245, respectively	82,617	123,482
Deposits and other assets	296,412	286,073
Total assets	9,172,091	8,924,509
Current liabilities:	'	'
Accounts payable and accrued expenses	8,284,275	7,530,034
Capital lease obligations, current	321,847	221,461
Notes payable, current	34,945	55,293
Due to factor	63,245	246,221
Deferred revenue	175,606	53,216
Total current liabilities	8,879,918	8,106,225
Long term liabilities:	'	'
Notes payable, long term	0	11,059
Capital lease obligations, long term	197,132	493,045
Total liabilities	9,077,050	8,610,329
Commitments and contingencies	'	'
Stockholders' equity:	'	'
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 17,564,164 and 16,970,465 shares issued and outstanding, respectively	17,564	16,970
Additional paid-in capital	15,317,537	14,213,443
Accumulated deficit	-15,258,074	-13,992,238
Accumulated other comprehensive income	18,014	76,005
Total stockholders' equity	95,041	314,180
Total liabilities and stockholders' equity	$9,172,091	$8,924,509

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets [Parenthetical] (USD $)	Mar. 31, 2014	Jun. 30, 2013
Trade receivables, allowance	$226,425	$211,743
Property and equipment, accumulated depreciation	1,418,441	1,094,953
Intangible Assets, accumulated amortization	$390,086	$308,245
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	17,564,164	16,970,465
Common stock, shares outstanding	17,564,164	16,970,465

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations and Other Comprehensive Loss (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Revenue	$8,642,184	$10,646,757	$26,842,284	$34,170,854
Cost of revenue	6,585,690	8,387,352	20,560,508	26,995,904
Gross profit	2,056,494	2,259,405	6,281,776	7,174,950
Operating expenses:	'	'	'	'
Selling, general and administrative	2,581,599	2,355,007	7,113,874	6,760,418
Depreciation and amortization	127,142	140,335	365,457	461,907
Loss on facility sublease	0	233,015	0	233,015
Gain on sale of fixed assets	0	-10,130	0	-17,009
Total operating expenses	2,708,741	2,718,227	7,479,331	7,438,331
Loss from operations	-652,247	-458,822	-1,197,555	-263,381
Other income (expenses)	'	'	'	'
Interest expense	-13,516	-16,946	-41,441	-76,506
Other income (expense)	-6,510	-8,142	-12,899	-18,056
Total other expense	-20,026	-25,088	-54,340	-94,562
Loss before provision for income taxes	-672,273	-483,910	-1,251,895	-357,943
Provision for income taxes	-4,060	8,476	-13,941	6,795
Net loss	-676,333	-475,434	-1,265,836	-351,148
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation	-468	46,049	-57,991	-19,201
Comprehensive loss	($676,801)	($429,385)	($1,323,827)	($370,349)
Net loss per share:	'	'	'	'
Basic and diluted	($0.04)	($0.03)	($0.07)	($0.02)
Weighted average shares outstanding:	'	'	'	'
Basic and diluted	17,392,213	17,254,551	17,176,541	17,181,559

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Jun. 30, 2013	$314,180	$16,970	$14,213,443	($13,992,238)	$76,005
Balance (in shares) at Jun. 30, 2013	'	16,970,465	'	'	'
Fair value of vested stock options	188,380	0	188,380	0	0
Fair value of common stock issued for services	78,308	175	78,133	0	0
Fair value of common stock issued for services (in shares)	'	174,699	'	'	'
Common shares issued upon exercise of warrants (in shares)	'	419,000	'	'	'
Common shares issued upon exercise of warrants	838,000	419	837,581	0	0
Net loss for the period	-1,265,836	0	0	-1,265,836	0
Foreign currency translation	-57,991	0	0	0	-57,991
Balance at Mar. 31, 2014	$95,041	$17,564	$15,317,537	($15,258,074)	$18,014
Balance (in shares) at Mar. 31, 2014	'	17,564,164	'	'	'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flow from operating activities:	'	'
Net loss	($1,265,836)	($351,148)
Adjustment to reconcile net loss to net cash used in operating activities:	'	'
Depreciation and amortization	365,457	488,883
Fair value of vested stock options	188,380	267,501
Fair value of common stock issued for services	78,308	0
Gain on sale of fixed assets	0	-17,009
Loss on facility sublease	0	233,015
Changes in assets and liabilities:	'	'
Accounts receivable	-418,605	828,753
Inventory	68,563	90,337
Due from factor	165,971	-131,491
Prepaid expenses and other current assets	-161,282	-141,552
Prepaid royalties	-202,160	114,077
Deposits and other assets	-10,339	-5,837
Accounts payable and accrued expenses	754,241	-1,549,370
Deferred revenue	122,390	24,432
Net cash used in operating activities	-314,912	-149,409
Cash flow from investing activities:	'	'
Purchase of property and equipment	-34,312	-97,662
Purchase of intangible assets	-40,976	0
Proceeds from sale of fixed assets	0	76,357
Net cash used in investing activities	-75,288	-21,305
Cash flow from financing activities:	'	'
Advances (payments) to factor	-182,976	54,846
Payment of notes payable	-31,407	-30,631
Payment of capital lease obligations	-195,527	-460,921
Payments under line of credit	0	-1,000,000
Issuance of shares upon exercise of warrants for cash	838,000	0
Net cash provided by (used in) financing activities	428,090	-1,436,706
Effect of exchange rate changes	-89,357	-39,554
Net decrease in cash and cash equivalents	-51,467	-1,646,974
Cash and cash equivalents, beginning of period	1,699,969	3,150,978
Cash and cash equivalents, end of period	1,648,502	1,504,004
Supplemental disclosures of cash flow information:	'	'
Cash paid for income taxes	13,941	-6,795
Cash paid for interest	41,441	76,506
Supplemental disclosures of non-cash investing and financing activities:	'	'
Acquisition of customer list through issuance of common shares	$0	$154,908

Organization_Nature_of_Busines

Organization, Nature of Business and Basis of Presentation	9 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation Of Financial Statements [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	Note 1. Organization, Nature of Business and Basis of Presentation
	Organization
	Research Solutions, Inc. (the “Company,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006.  On March 4, 2013, we consummated a merger with DYSC Subsidiary Corporation, our wholly-owned subsidiary, pursuant to which we, in connection with such merger, amended our Articles of Incorporation to change our name to Research Solutions, Inc. (formerly Derycz Scientific, Inc.). Research Solutions, Inc. is a publicly traded holding company with three wholly owned subsidiaries: Reprints Desk, Inc., a Delaware corporation (“Reprints Desk”); Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico (“Reprints Desk Latin America”); and Techniques Appliquées aux Arts Graphiques, S.p.A. (“TAAG”), an entity organized under the laws of France.
	Business Overview
	We provide research solutions that facilitate the flow of information from the publishers of scientific, technical, and medical (“STM”) content to enterprise customers in life science and other research intensive organizations around the world. We provide customers with access to hundreds of thousands of newly published articles each year in addition to the tens of millions of existing articles that have been published in the past, helping them to identify the most useful and relevant content for their activities. In addition to serving end users of content, we also serve STM publishers by facilitating compliance with applicable copyright laws. We have developed proprietary software and Internet-based interfaces that allow customers to find, electronically receive and legally use the content that is critical to their research.
	We have two reportable diverse geographical concentrations: North American Operations, which consists of Reprints Desk and Reprints Desk Latin America, and France, which consists of TAAG.
	We provide three types of services to our customers: Article Galaxy, Reprints and ePrints and Printing and Logistics.
	Article Galaxy
	Researchers and regulatory personnel in life science and other research intensive organizations generally require single copies of published STM journal articles for use in their research activities. They place orders with us for the articles they need and we source and electronically deliver the requested content to them generally in under an hour. This service is known in the industry as single article delivery or document delivery. We also obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. We have arrangements with numerous content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Even though single article delivery services are charged on a transactional basis, customer order volume tends to be consistent from month to month in part due to consistent orders of larger customers that require the implementation of our services into their work flow, subject to fluctuations due to the addition or loss of customers.
	We deliver the aforementioned services through our Article Galaxy journal article platform (“Article Galaxy”), which consists of proprietary software and Internet-based interfaces that allow customers to initiate orders, manage transactions, obtain reporting, automate authentication, improve seamless connectivity to corporate intranets, and enhance the information resources they already own, or have access to via subscriptions or internal libraries, as well as organize workgroups to collaborate around scientific information.
	As a cloud-based software-as-a-service (SaaS) solution, Article Galaxy is deployed as a single system across our entire customer base. Customers access Article Galaxy securely through online web interfaces and via web service APIs, which enable customers to leverage Article Galaxy features and functionality from within proprietary and other 3rd party software systems. Article Galaxy can also be configured to satisfy a customer’s individual preferences in areas such as user experience, business processes, and spend management. As a SaaS solution, Article Galaxy benefits from efficiencies in scalability, stability and development costs, resulting in significant advantages versus multiple instance or installed desktop software alternatives. We leverage these technical efficiencies to fuel rapid innovation and competitive advantage.
	Reprints and ePrints
	Marketing departments in life science and other research intensive organizations generally require large quantities of printed copies of published STM journal articles called “Reprints.” They generally supply Reprints to doctors who may prescribe their products and at conferences. We obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. The majority of content publishers print their content in-house and prohibit others from printing their content, however, when not prohibited by the content publisher, we use a third party to print Reprint orders delivered to North American customers, and TAAG to print Reprint orders delivered to mostly European customers. Electronic copies, called “ePrints,” are also used for distribution through the Internet and other electronic mechanisms. We have developed proprietary ePrint software that increase the efficiency of our customers’ content purchases by transitioning from paper reprints to electronic ePrints, and by improving compliance with applicable copyright laws and promotional regulations within the life science industry. Reprints and ePrints are charged on a transactional basis and order volume typically fluctuates from month to month based on customer marketing budgets and the existence of STM journal articles that fit customer requirements.
	Printing and Logistics
	Our printing and logistics services, performed by TAAG, include a variety of hard copy, professionally printed materials that are used for retail and marketing purposes, including Reprints, as well as regulatory sensitive marketing materials and clinical trial kits. The majority of TAAG’s customers are in France. Only a small percentage of the printing work performed by TAAG is for Reprint orders for our North American operations delivered to mostly European customers. TAAG possesses sufficient operational capacity to handle additional orders from customers.
	Liquidity
	Historically, we have relied upon cash from financing activities to fund substantially all of the cash requirements of our activities and have incurred significant losses and experienced negative cash flow. As of March 31, 2014, we had an accumulated deficit of $15,258,074 and stockholders’ equity of $95,041. For the nine months ended March 31, 2014, the Company recorded a net loss of $1,265,836 and cash used in operating activities was $314,912. We cannot predict if we will be profitable. We may continue to incur losses for an indeterminate period of time and may never sustain profitability. An extended period of losses and negative cash flow may prevent us from successfully operating and expanding our business. We may be unable to achieve and maintain profitability on a quarterly or annual basis.
	North American Operations (Reprints Desk and Reprints Desk Latin America)
	The Company believes that its current cash resources and expected cash flow from its North American operations will be sufficient to sustain current North American operations for the next twelve months. The Company expects that cash flow from its North American operating activities will continue to be positive; however, there are no assurances that such results will be achieved.
	France (TAAG)
	The Company believes that its current cash resources and expected cash flow from TAAG may not be sufficient to sustain TAAG operations for the next twelve months. During the nine months ended March 31, 2014, TAAG incurred a net loss from operations of $208,331, and at March 31, 2014, had a working capital deficiency of approximately $1,680,000. In addition, significant net losses in prior years have been incurred. As of March 31, 2014, approximately $700,000 of payroll and VAT taxes were delinquent. In January 2014, the French tax authorities agreed to a repayment plan for the entire balance of delinquent payroll and VAT taxes consisting of 24 monthly payments of approximately $35,000 beginning in February 2014. Effective June 30, 2013, we forgave a loan receivable from TAAG totaling $1,009,115 to improve TAAG’s liquidity. Our line of credit with Silicon Valley Bank limits the amount of funding of TAAG to a maximum of $279,333 through June 30, 2014, and $50,000 per year thereafter. In addition, the lesser of $750,000 or 5% of the funds raised in a registered public offering can be used to fund TAAG through March 31, 2015. No additional financing for TAAG is in place. In the event that TAAG liquidates our exposure to creditors in France is limited to the assets of TAAG, with the exception of a $50,000 guarantee by us in favor of the landlord on the facility lease. In the event that TAAG liquidates we would lose a significant percentage of revenue, or all revenue, from TAAG.
	Principles of Consolidation
	The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation.
	Basis of Presentation
	The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013 filed with the SEC. The condensed consolidated balance sheet as of June 30, 2013 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP.
	In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	Note 2. Summary of Significant Accounting Policies
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.
	These estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer's financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required.
	Cash denominated in Euros with a US Dollar equivalent of $191,349 and $393,093 at March 31, 2014 and June 30, 2013, respectively, was held in accounts at financial institutions located in Europe.
	The following table summarizes accounts receivable concentrations:
		As of March 31, 2014				As of June 30, 2013
	Customer A			*			11	%
	The following table summarizes revenue concentrations:
			Three Months Ended							Nine Months Ended
			March 31,							March 31,
			2014			2013				2014			2013
	Customer A			*			*				13	%		12	%
	Customer B			*			16	%			*			11	%
	The following table summarizes vendor concentrations:
			Three Months Ended								Nine Months Ended
			March 31,								March 31,
			2014				2013				2014				2013
	Vendor A			18	%			13	%			23	%			19	%
	Vendor B			11	%			14	%			11	%			*
	Vendor C			*				*				11	%			*
	* Less than 10%
	Revenue Recognition
	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing three types of services to our customers: Article Galaxy, Reprints and ePrints, and Printing and Logistics.
	Article Galaxy
	We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known in the industry as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Reprints and ePrints
	We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content, however, when not prohibited by the content publisher, we use a third party to print Reprint orders delivered to North American customers, and TAAG to print Reprint orders delivered to mostly European customers. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Printing and Logistics
	We charge a transactional fee for each order of hard copy printed material. We are responsible for printing and delivering the order. Printing and Logistics services are exclusively performed by TAAG, our French operating subsidiary. The majority of TAAG’s customers are in France. Only a small percentage of the printing work performed by TAAG is for Reprint orders for our North American operations delivered to mostly European customers. We recognize revenue from printing services when the printed materials have been shipped to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Stock-Based Compensation
	The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations.  The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete.  Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
	Foreign Currency Translation
	The accompanying condensed consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the revenues and costs of TAAG are in Euros, and the costs of Reprints Desk Latin America are in Mexican pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.
	The following table summarizes the exchange rates used:
			Nine Months Ended						Year Ended
			March 31,						June 30,
			2014			2013			2013			2012
	Period end Euro : US Dollar exchange rate			1.38			1.28			1.3			1.26
	Average period Euro : US Dollar exchange rate			1.35			1.29			1.29			1.34
	Period end Mexican Peso : US Dollar exchange rate			0.08			0.08			0.08			0.08
	Average period Mexican Peso : US Dollar exchange rate			0.08			0.08			0.08			0.08
	Net Income (Loss) Per Share
	Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted net income per share is computed similar to basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive securities had been issued. At March 31, 2014 potentially dilutive securities include options to acquire 1,885,437 shares of common stock and warrants to acquire 907,998 shares of common stock.  At March 31, 2013 potentially dilutive securities include options to acquire 1,680,898 shares of common stock and warrants to acquire 2,376,173 shares of common stock. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.
	Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, excluding unvested restricted common stock. Basic and diluted net loss per common share is the same for all periods presented with a net loss because all warrants and stock options outstanding are anti-dilutive.
	The calculation of basic and diluted net income (loss) per share is presented below:
			Three Months Ended						Nine Months Ended
			March 31,						March 31,
			2014			2013			2014			2013
	Numerator:
	Net income (loss)		$	-676,333		$	-475,434		$	-1,265,836		$	-351,148
	Denominator:
	Weighted average shares outstanding (basic)			17,392,213			17,254,551			17,176,541			17,181,559
	Effect of diluted securities			-			-			-			-
	Weighted average shares outstanding (diluted)			17,392,213			17,254,551			17,176,541			17,181,559
	Net income (loss) per share:
	Basic		$	-0.04		$	-0.03		$	-0.07		$	-0.02
	Diluted		$	-0.04		$	-0.03		$	-0.07		$	-0.02
	Recently Issued Accounting Pronouncements
	In April 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)."  ASU 2014-08 amends the requirements for reporting discontinued operations and requires additional disclosures about discontinued operations.  Under the new guidance, only disposals representing a strategic shift in operations or that have a major effect on the Company's operations and financial results should be presented as discontinued operations.  This new accounting guidance is effective for annual periods beginning after December 15, 2014.  The Company is currently evaluating the impact of adopting ASU 2014-08 on the Company's results of operations or financial condition.
	Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Line_of_Credit

Line of Credit	9 Months Ended
	Mar. 31, 2014
Line Of Credit Facility [Abstract]	'
Line Of Credit Facility Disclosure [Text Block]	'
	Note 3. Line of Credit
	The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $4,000,000, or 80% of eligible accounts receivable.  The line of credit matures on October 31, 2015, and is subject to certain financial and performance covenants with which we were in compliance as of March 31, 2014. Financial covenants are measured on North American operations only and include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2013, plus 50% of the dollar value of equity issuances after October 1, 2013 (reduced to 40% of the dollar value of equity issuances in connection with the exercise of warrants in November 2013) and the principal amount of subordinated debt. The Company failed to comply with the tangible net worth covenant in December 2011 and July 2013. On both occasions the parties agreed to amend and reset the minimum tangible net worth required under the covenant. The line of credit bears interest at the prime rate plus 2.5% for periods in which the Company maintains an account balance with SVB (less all indebtedness owed to SVB) of at least $800,000 at all times during the prior calendar month (the “Streamline Period”), and at the prime rate plus 5.25% when a Streamline Period is not in effect. The interest rate on the line of credit was 6.5% as of March 31, 2014. The line of credit is secured by all of the Company’s and its subsidiaries’ assets, excluding TAAG’s assets.
	Our line of credit with SVB limits the amount of funding of TAAG to a maximum of $279,333 through June 30, 2014, and $50,000 per year thereafter. In addition, the lesser of $750,000 or 5% of the funds raised in a registered public offering can be used to fund TAAG through March 31, 2015.
	There were no outstanding borrowings under the line as of March 31, 2014 and June 30, 2013, respectively.  As of March 31, 2014 and June 30, 2013, approximately $2,116,000 and $2,000,000, respectively, of available credit was unused under the line of credit.

Factor_Agreements

Factor Agreements	9 Months Ended
	Mar. 31, 2014
Factor Agreements [Abstract]	'
Significant Agreements Disclosure [Text Block]	'
	Note 4. Factor Agreements
	TAAG has factoring agreements with Credit Cooperatif and Natixis for working capital and credit administration purposes.  Under the agreements, the factors purchase trade accounts receivable assigned to them by TAAG.  The accounts are sold (with recourse) at the invoice amount subject to a factor commission and other miscellaneous fees.  Trade accounts receivable not sold remain in TAAG's custody and control and TAAG maintains all credit risk on those accounts.
	On September 10, 2013, TAAG terminated its factoring agreement with ABN Amro.  As of March 31, 2014 and June 30, 2013, $0 and $165,971 was due from ABN Amro, respectively.
	Under the factoring agreement with Credit Cooperatif, TAAG can borrow up to approximately $325,000 (Euro 250,000).  The factor fee is determined on a case by case basis and is not specified in the agreement.  The fee charged for the obligations outstanding is approximately 5%.  As of March 31, 2014 and June 30, 2013, $0 and $246,221 was due to Credit Cooperatif, respectively, that relate to funds paid to TAAG not yet returned to the factor.
	On May 3, 2013, TAAG entered into a factoring agreement with Natixis. The maximum amount TAAG can borrow is not specified in the agreement.  The factor fee is determined based on TAAG's revenue and the average amount of customer invoices.  The fee charged for the obligations outstanding as of March 31, 2014 was approximately 0.45%.  In addition, interest is charged on the amount financed at the three month Euribor interest rate plus 1.6%. The interest rate under the agreement was approximately 1.8% per annum at March 31, 2014.  As of March 31, 2014 and June 30, 2013, $63,245 and $0 was due to Natixis, respectively, that relate to funds paid to TAAG not yet returned to the factor.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity Note Disclosure [Text Block]	'
	Note 5. Stockholders’ Equity
	Stock Options
	In December 2007, we established the 2007 Equity Compensation Plan (the “Plan”). The Plan was approved by our board of directors and stockholders. The purpose of the Plan is to grant stock and options to purchase our common stock to our employees, directors and key consultants. On November 15, 2012, the maximum number of shares of common stock that may be issued pursuant to awards granted under the Plan increased from 1,500,000 to 3,000,000, as approved by our board of directors and stockholders. Cancelled and forfeited stock options and stock awards may again become available for grant under the Plan. There were 823,339 shares available for grant under the Plan as of March 31, 2014. All current stock option grants are made under the 2007 Equity Compensation Plan.
	The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period.
	The following table summarizes vested and unvested stock option activity:
			All Options						Vested Options					Unvested Options
			Shares			Weighted			Shares			Weighted		Shares		Weighted
						Average						Average				Average
						Exercise						Exercise				Exercise
						Price						Price				Price
	Outstanding at June 30, 2013			1,692,898			1.24			1,352,730			1.23		340,168		1.29
	Granted			192,539			1.8			7,400			1.8		185,139		1.8
	Options vesting			-			-			147,084			1.28		-147,084		1.28
	Exercised			-			-			-			-		-		-
	Forfeited/Cancelled			-			-			-			-		-		-
	Outstanding at March 31, 2014			1,885,437		$	1.3			1,507,214		$	1.24		378,223	$	1.54
	The weighted average remaining contractual life of all options outstanding as of March 31, 2014 was 6.68 years. The weighted average remaining contractual life for options vested and exercisable at March 31, 2014 was 6.35 years. Furthermore, the aggregate intrinsic value of all options outstanding as of March 31, 2014 was $1,317,556, and the aggregate intrinsic value of options vested and exercisable at March 31, 2014 was $1,180,409, in each case based on the fair value of the Company’s common stock on March 31, 2014. The total fair value of options vested during the nine months ended March 31, 2014 was $188,380 and is included in selling, general and administrative expenses in the accompanying statement of operations.  As of March 31, 2014, the amount of unvested compensation related to these options was $352,370 which will be recorded as an expense in future periods as the options vest.
	Additional information regarding stock options outstanding and exercisable as of March 31, 2014 is as follows:
	Option			Options			Remaining			Options
	Exercise			Outstanding			Contractual			Exercisable
	Price						Life (in years)
	$	1			347,000			5.16			347,000
		1.02			287,000			6.33			287,000
		1.07			53,898			8.55			43,898
		1.15			278,000			8.86			203,333
		1.25			32,000			8.88			13,333
		1.3			263,000			7.93			197,250
		1.5			380,000			3.81			380,000
		1.75			1,067			9.84			-
		1.8			190,050			9.48			7,400
		1.85			24,000			9.14			-
		1.97			1,422			9.65			-
		3			15,000			6.79			15,000
		3.05			10,000			6.87			10,000
		3.65			3,000			6.98			3,000
		Total			1,885,437						1,507,214
	Warrants
	The following table summarizes warrant activity:
			Number of			Weighted
			Warrants			Average
						Exercise
						Price
	Outstanding, June 30, 2013			2,376,173			2.06
	Granted			-			-
	Exercised			-419,000			2
	Expired			-1,052,175			2.37
	Outstanding, March 31, 2014			904,998		$	1.73
	Exercisable, June 30, 2013			2,376,173		$	2.06
	Exercisable, March 31, 2014			904,998		$	1.73
	The intrinsic value for all warrants outstanding as of March 31, 2014 was $304,666, based on the fair value of the Company’s common stock on March 31, 2014.
	In November 2013, warrant holders exercised warrants to purchase 419,000 shares of the Company’s common stock for $838,000.
	Additional information regarding warrants outstanding and exercisable as of March 31, 2014 is as follows:
	Warrant			Warrants			Remaining			Warrants Exercisable
	Exercise Price			Outstanding			Contractual
							Life (in years)
	$	1.19			150,000			7.73			150,000
		1.25			150,000			1.6			150,000
		1.75			333,331			0.64			333,331
		2.25			266,667			0.73			266,667
		3.5			2,500			2.25			2,500
		4			2,500			2.25			2,500
		Total			904,998						904,998
	Restricted Common Stock
On September 6, 2013, the Company issued 150,833 shares of restricted common stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $271,499 based on the market price of our common stock of $1.80 per share on the date of grant, which will be amortized over the three year vesting period.
On November 22, 2013, the Company issued 11,683 shares of restricted common stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $23,016 based on the market price of our common stock of $1.97 per share on the date of grant, which will be amortized over the three year vesting period.
On January 28, 2014, the Company issued 9,435 shares of restricted common stock to employees. These shares vest over a three year period, with a one year cliff vesting period, and remain subject to forfeiture if vesting conditions are not met. The aggregate value of the stock award was $16,511 based on the market price of our common stock of $1.75 per share on the date of grant, which will be amortized over the three year vesting period.
The total fair value of restricted common stock vested during the nine months ended March 31, 2014 was $73,087 and is included in selling, general and administrative expenses in the accompanying statement of operations. As of March 31, 2014, the amount of unvested compensation related to these issuances of restricted common stock was $237,939 which will be recorded as an expense in future periods as the stock vests. When calculating net income (loss) per share, these shares are included in weighted average common shares outstanding from the time they vest.
The following table summarizes restricted common stock activity:
		Number of			Weighted
		Shares			Average
					Grant Date
					Fair Value
Non-vested, June 30, 2013			33,939			1.85
Granted			171,951			1.81
Vested			-			-
Forfeited			-			-
Non-vested, March 31, 2014			205,890		$	1.82
Issuance of Common Stock
On December 6, 2013, the Company issued 2,748 shares of common stock valued at $5,222 to a consultant for services rendered.

Geographical_Information

Geographical Information	9 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	Note 6. Geographical Information
	As of March 31, 2014, the Company had two reportable diverse geographical concentrations:  North American Operations, which consists of Reprints Desk and Reprints Desk Latin America, and France, which consists of TAAG.  Information related to these operating segments, net of eliminations, consists of the following for the periods below:
		Three Months Ended						Nine Months Ended
		March 31, 2014						March 31, 2014
		North		France		Total		North		France		Total
		American		(TAAG)				American		(TAAG)
		Operations						Operations
	Revenue	$	6,791,278	$	1,850,906	$	8,642,184	$	20,791,856	$	6,050,428	$	26,842,284
	Cost of revenue		5,392,784		1,192,906		6,585,690		16,880,209		3,680,299		20,560,508
	Selling, general and administrative expenses		1,788,319		793,280		2,581,599		4,746,191		2,367,683		7,113,874
	Depreciation and amortization		56,359		70,783		127,142		154,680		210,777		365,457
	Loss from operations	$	-446,184	$	-206,063	$	-652,247	$	-989,224	$	-208,331	$	-1,197,555
		Three Months Ended March 31, 2013						Nine Months Ended
								March 31, 2013
		North		France		Total		North		France		Total
		American		(TAAG)				American		(TAAG)
		Operations						Operations
	Revenue	$	7,878,181	$	2,768,576	$	10,646,757	$	26,525,404	$	7,645,450	$	34,170,854
	Cost of revenue		6,714,629		1,672,723		8,387,352		22,399,973		4,595,931		26,995,904
	Selling, general and administrative expenses		1,387,339		967,668		2,355,007		3,752,936		3,007,482		6,760,418
	Depreciation and amortization		47,857		92,478		140,335		185,324		276,583		461,907
	Loss on facility sublease		233,015		-		233,015		233,015		-		233,015
	Gain on sale of fixed assets		-		-10,130		-10,130		-18,630		1,621		-17,009
	Income (loss) from operations	$	-504,659	$	45,837	$	-458,822	$	-27,214	$	-236,167	$	-263,381
		As of March 31, 2014						As of June 30, 2013
		North		France		Total		North		France		Total
		American		(TAAG)				American		(TAAG)
		Operations						Operations
	Current assets	$	6,617,095	$	1,562,674	$	8,179,769	$	5,536,474	$	2,147,249	$	7,683,723
	Property and equipment, net		120,818		492,475		613,293		189,596		641,635		831,231
	Intangible assets, net		82,617		-		82,617		123,482		-		123,482
	Other non-current assets		9,698		286,714		296,412		9,712		276,361		286,073
	Total assets	$	6,830,228	$	2,341,863	$	9,172,091	$	5,859,264	$	3,065,245		8,924,509
	Current liabilities	$	5,637,413	$	3,242,505	$	8,879,918	$	4,732,746	$	3,373,479		8,106,225
	Long term liabilities		-		197,132		197,132		-		504,104		504,104
	Equity		1,192,815		-1,097,774		95,041		1,126,518		-812,338		314,180
	Total liabilities and equity	$	6,830,228	$	2,341,863	$	9,172,091	$	5,859,264	$	3,065,245	$	8,924,509

Subsequent_Events

Subsequent Events	9 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	Note 7. Subsequent Events
	On May 2, 2014, stockholders voted to authorize the board of directors to effectuate, in its discretion, an amendment to the Company’s Articles of Incorporation, as amended, to effectuate a reverse stock split of the Company’s common stock of no less than 1-for-2 and no greater than 1-for-8 at any time before December 31, 2014, with special treatment for certain stockholders to preserve round lot holders.
	The reverse stock split would become effective upon the filing of the amendment to the Company’s Articles of Incorporation, as amended, with the Secretary of State of the State of Nevada, or at the later time set forth in the amendment. The exact timing of the amendment will be determined by the board of directors based on its evaluation as to if and when such action will be the most advantageous to the Company and its stockholders. In addition, the board of directors reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to abandon the amendment and the reverse stock split if, at any time prior to the effectiveness of the filing of the amendment with the Secretary of State of the State of Nevada, the board of directors, in its sole discretion, determines that it is no longer in the best interest of the Company and its stockholders to proceed.
	The board of directors’ primary reason for approving and recommending the reverse stock split is to increase the per share price of the Company’s common stock to meet the listing requirements of the NASDAQ Capital Market (“NASDAQ”). The board of directors believes that attaining and maintaining the listing of the Company’s common stock on NASDAQ is in the best interests of the Company and its stockholders.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Use of Estimates, Policy [Policy Text Block]	'
	Use of Estimates
	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates.
	These estimates and assumptions include estimates for reserves of uncollectible accounts, inventory obsolescence, analysis of impairments of recorded goodwill and intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
Concentrations Credit Risk Policy [Policy Text Block]	'
	Concentration of Credit Risk
	Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $250,000 insurance limit. The Company does not anticipate incurring any losses related to these credit risks. The Company extends credit based on an evaluation of the customer's financial condition, generally without collateral. Exposure to losses on receivables is principally dependent on each customer's financial condition. The Company monitors its exposure for credit losses and intends to maintain allowances for anticipated losses, as required.
	Cash denominated in Euros with a US Dollar equivalent of $191,349 and $393,093 at March 31, 2014 and June 30, 2013, respectively, was held in accounts at financial institutions located in Europe.
	The following table summarizes accounts receivable concentrations:
		As of March 31, 2014				As of June 30, 2013
	Customer A			*			11	%
	The following table summarizes revenue concentrations:
			Three Months Ended							Nine Months Ended
			March 31,							March 31,
			2014			2013				2014			2013
	Customer A			*			*				13	%		12	%
	Customer B			*			16	%			*			11	%
	The following table summarizes vendor concentrations:
			Three Months Ended								Nine Months Ended
			March 31,								March 31,
			2014				2013				2014				2013
	Vendor A			18	%			13	%			23	%			19	%
	Vendor B			11	%			14	%			11	%			*
	Vendor C			*				*				11	%			*
	* Less than 10%
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing three types of services to our customers: Article Galaxy, Reprints and ePrints, and Printing and Logistics.
	Article Galaxy
	We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service, known in the industry as single article delivery or document delivery, generates nearly all of the revenue attributable to the Article Galaxy journal article platform. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Reprints and ePrints
	We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content, however, when not prohibited by the content publisher, we use a third party to print Reprint orders delivered to North American customers, and TAAG to print Reprint orders delivered to mostly European customers. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
	Printing and Logistics
	We charge a transactional fee for each order of hard copy printed material. We are responsible for printing and delivering the order. Printing and Logistics services are exclusively performed by TAAG, our French operating subsidiary. The majority of TAAG’s customers are in France. Only a small percentage of the printing work performed by TAAG is for Reprint orders for our North American operations delivered to mostly European customers. We recognize revenue from printing services when the printed materials have been shipped to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	The Company periodically issues stock options and warrants to employees and non-employees in capital raising transactions, for services and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of share-based payment awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations.  The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete.  Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	'
	Foreign Currency Translation
	The accompanying condensed consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the revenues and costs of TAAG are in Euros, and the costs of Reprints Desk Latin America are in Mexican pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities.
	The following table summarizes the exchange rates used:
			Nine Months Ended						Year Ended
			March 31,						June 30,
			2014			2013			2013			2012
	Period end Euro : US Dollar exchange rate			1.38			1.28			1.3			1.26
	Average period Euro : US Dollar exchange rate			1.35			1.29			1.29			1.34
	Period end Mexican Peso : US Dollar exchange rate			0.08			0.08			0.08			0.08
	Average period Mexican Peso : US Dollar exchange rate			0.08			0.08			0.08			0.08
Earnings Per Share, Policy [Policy Text Block]	'
	Net Income (Loss) Per Share
	Basic net income per share is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted net income per share is computed similar to basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive securities had been issued. At March 31, 2014 potentially dilutive securities include options to acquire 1,885,437 shares of common stock and warrants to acquire 907,998 shares of common stock.  At March 31, 2013 potentially dilutive securities include options to acquire 1,680,898 shares of common stock and warrants to acquire 2,376,173 shares of common stock. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period.
	Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, excluding unvested restricted common stock. Basic and diluted net loss per common share is the same for all periods presented with a net loss because all warrants and stock options outstanding are anti-dilutive.
	The calculation of basic and diluted net income (loss) per share is presented below:
			Three Months Ended						Nine Months Ended
			March 31,						March 31,
			2014			2013			2014			2013
	Numerator:
	Net income (loss)		$	-676,333		$	-475,434		$	-1,265,836		$	-351,148
	Denominator:
	Weighted average shares outstanding (basic)			17,392,213			17,254,551			17,176,541			17,181,559
	Effect of diluted securities			-			-			-			-
	Weighted average shares outstanding (diluted)			17,392,213			17,254,551			17,176,541			17,181,559
	Net income (loss) per share:
	Basic		$	-0.04		$	-0.03		$	-0.07		$	-0.02
	Diluted		$	-0.04		$	-0.03		$	-0.07		$	-0.02
New accounting Pronouncements Policy [Policy Text Block]	'
	Recently Issued Accounting Pronouncements
	In April 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-08, "Presentation of Financial Statements (Topic 205) and Property, Plant and Equipment (Topic 360)."  ASU 2014-08 amends the requirements for reporting discontinued operations and requires additional disclosures about discontinued operations.  Under the new guidance, only disposals representing a strategic shift in operations or that have a major effect on the Company's operations and financial results should be presented as discontinued operations.  This new accounting guidance is effective for annual periods beginning after December 15, 2014.  The Company is currently evaluating the impact of adopting ASU 2014-08 on the Company's results of operations or financial condition.
	Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA, and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	The following table summarizes accounts receivable concentrations:
		As of March 31, 2014				As of June 30, 2013
	Customer A			*			11	%
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]	'
	The following table summarizes revenue concentrations:
			Three Months Ended							Nine Months Ended
			March 31,							March 31,
			2014			2013				2014			2013
	Customer A			*			*				13	%		12	%
	Customer B			*			16	%			*			11	%
Fair Value, Concentration of Risk [Table Text Block]	'
	The following table summarizes vendor concentrations:
			Three Months Ended								Nine Months Ended
			March 31,								March 31,
			2014				2013				2014				2013
	Vendor A			18	%			13	%			23	%			19	%
	Vendor B			11	%			14	%			11	%			*
	Vendor C			*				*				11	%			*
	* Less than 10%
Schedule Of Foreign Currency Exchange Rate [Table Text Block]	'
	The following table summarizes the exchange rates used:
			Nine Months Ended						Year Ended
			March 31,						June 30,
			2014			2013			2013			2012
	Period end Euro : US Dollar exchange rate			1.38			1.28			1.3			1.26
	Average period Euro : US Dollar exchange rate			1.35			1.29			1.29			1.34
	Period end Mexican Peso : US Dollar exchange rate			0.08			0.08			0.08			0.08
	Average period Mexican Peso : US Dollar exchange rate			0.08			0.08			0.08			0.08
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	The calculation of basic and diluted net income (loss) per share is presented below:
			Three Months Ended						Nine Months Ended
			March 31,						March 31,
			2014			2013			2014			2013
	Numerator:
	Net income (loss)		$	-676,333		$	-475,434		$	-1,265,836		$	-351,148
	Denominator:
	Weighted average shares outstanding (basic)			17,392,213			17,254,551			17,176,541			17,181,559
	Effect of diluted securities			-			-			-			-
	Weighted average shares outstanding (diluted)			17,392,213			17,254,551			17,176,541			17,181,559
	Net income (loss) per share:
	Basic		$	-0.04		$	-0.03		$	-0.07		$	-0.02
	Diluted		$	-0.04		$	-0.03		$	-0.07		$	-0.02

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Mar. 31, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
	The following table summarizes vested and unvested stock option activity:
			All Options						Vested Options					Unvested Options
			Shares			Weighted			Shares			Weighted		Shares		Weighted
						Average						Average				Average
						Exercise						Exercise				Exercise
						Price						Price				Price
	Outstanding at June 30, 2013			1,692,898			1.24			1,352,730			1.23		340,168		1.29
	Granted			192,539			1.8			7,400			1.8		185,139		1.8
	Options vesting			-			-			147,084			1.28		-147,084		1.28
	Exercised			-			-			-			-		-		-
	Forfeited/Cancelled			-			-			-			-		-		-
	Outstanding at March 31, 2014			1,885,437		$	1.3			1,507,214		$	1.24		378,223	$	1.54
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	'
	Additional information regarding stock options outstanding and exercisable as of March 31, 2014 is as follows:
	Option			Options			Remaining			Options
	Exercise			Outstanding			Contractual			Exercisable
	Price						Life (in years)
	$	1			347,000			5.16			347,000
		1.02			287,000			6.33			287,000
		1.07			53,898			8.55			43,898
		1.15			278,000			8.86			203,333
		1.25			32,000			8.88			13,333
		1.3			263,000			7.93			197,250
		1.5			380,000			3.81			380,000
		1.75			1,067			9.84			-
		1.8			190,050			9.48			7,400
		1.85			24,000			9.14			-
		1.97			1,422			9.65			-
		3			15,000			6.79			15,000
		3.05			10,000			6.87			10,000
		3.65			3,000			6.98			3,000
		Total			1,885,437						1,507,214
Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options [Table Text Block]	'
	The following table summarizes warrant activity:
			Number of			Weighted
			Warrants			Average
						Exercise
						Price
	Outstanding, June 30, 2013			2,376,173			2.06
	Granted			-			-
	Exercised			-419,000			2
	Expired			-1,052,175			2.37
	Outstanding, March 31, 2014			904,998		$	1.73
	Exercisable, June 30, 2013			2,376,173		$	2.06
	Exercisable, March 31, 2014			904,998		$	1.73
Schedule Warrants Outstanding and Exercisable [Table Text Block]	'
	Additional information regarding warrants outstanding and exercisable as of March 31, 2014 is as follows:
	Warrant			Warrants			Remaining			Warrants Exercisable
	Exercise Price			Outstanding			Contractual
							Life (in years)
	$	1.19			150,000			7.73			150,000
		1.25			150,000			1.6			150,000
		1.75			333,331			0.64			333,331
		2.25			266,667			0.73			266,667
		3.5			2,500			2.25			2,500
		4			2,500			2.25			2,500
		Total			904,998						904,998
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	'
	The following table summarizes restricted common stock activity:
			Number of			Weighted
			Shares			Average
						Grant Date
						Fair Value
	Non-vested, June 30, 2013			33,939			1.85
	Granted			171,951			1.81
	Vested			-			-
	Forfeited			-			-
	Non-vested, March 31, 2014			205,890		$	1.82

Geographical_Information_Table

Geographical Information (Tables)	9 Months Ended
	Mar. 31, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	As of March 31, 2014, the Company had two reportable diverse geographical concentrations:  North American Operations, which consists of Reprints Desk and Reprints Desk Latin America, and France, which consists of TAAG.  Information related to these operating segments, net of eliminations, consists of the following for the periods below:
		Three Months Ended						Nine Months Ended
		March 31, 2014						March 31, 2014
		North		France		Total		North		France		Total
		American		(TAAG)				American		(TAAG)
		Operations						Operations
	Revenue	$	6,791,278	$	1,850,906	$	8,642,184	$	20,791,856	$	6,050,428	$	26,842,284
	Cost of revenue		5,392,784		1,192,906		6,585,690		16,880,209		3,680,299		20,560,508
	Selling, general and administrative expenses		1,788,319		793,280		2,581,599		4,746,191		2,367,683		7,113,874
	Depreciation and amortization		56,359		70,783		127,142		154,680		210,777		365,457
	Loss from operations	$	-446,184	$	-206,063	$	-652,247	$	-989,224	$	-208,331	$	-1,197,555
		Three Months Ended March 31, 2013						Nine Months Ended
								March 31, 2013
		North		France		Total		North		France		Total
		American		(TAAG)				American		(TAAG)
		Operations						Operations
	Revenue	$	7,878,181	$	2,768,576	$	10,646,757	$	26,525,404	$	7,645,450	$	34,170,854
	Cost of revenue		6,714,629		1,672,723		8,387,352		22,399,973		4,595,931		26,995,904
	Selling, general and administrative expenses		1,387,339		967,668		2,355,007		3,752,936		3,007,482		6,760,418
	Depreciation and amortization		47,857		92,478		140,335		185,324		276,583		461,907
	Loss on facility sublease		233,015		-		233,015		233,015		-		233,015
	Gain on sale of fixed assets		-		-10,130		-10,130		-18,630		1,621		-17,009
	Income (loss) from operations	$	-504,659	$	45,837	$	-458,822	$	-27,214	$	-236,167	$	-263,381
		As of March 31, 2014						As of June 30, 2013
		North		France		Total		North		France		Total
		American		(TAAG)				American		(TAAG)
		Operations						Operations
	Current assets	$	6,617,095	$	1,562,674	$	8,179,769	$	5,536,474	$	2,147,249	$	7,683,723
	Property and equipment, net		120,818		492,475		613,293		189,596		641,635		831,231
	Intangible assets, net		82,617		-		82,617		123,482		-		123,482
	Other non-current assets		9,698		286,714		296,412		9,712		276,361		286,073
	Total assets	$	6,830,228	$	2,341,863	$	9,172,091	$	5,859,264	$	3,065,245		8,924,509
	Current liabilities	$	5,637,413	$	3,242,505	$	8,879,918	$	4,732,746	$	3,373,479		8,106,225
	Long term liabilities		-		197,132		197,132		-		504,104		504,104
	Equity		1,192,815		-1,097,774		95,041		1,126,518		-812,338		314,180
	Total liabilities and equity	$	6,830,228	$	2,341,863	$	9,172,091	$	5,859,264	$	3,065,245	$	8,924,509

Organization_Nature_of_Busines1

Organization, Nature of Business and Basis of Presentation (Details Textual) (USD $)	3 Months Ended		9 Months Ended					1 Months Ended	9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Jan. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
						Through June 30 2014 [Member]	Thereafter [Member]	Taag [Member]	Taag [Member]	Taag [Member]
						Silicon Valley Bank [Member]	Silicon Valley Bank [Member]			Maximum [Member]
Organization Nature of Business and Basis of Presentation [Line Items]	'	'	'	'	'	'	'	'	'	'
Retained Earnings (Accumulated Deficit)	($15,258,074)	'	($15,258,074)	'	($13,992,238)	'	'	'	'	'
Operating Income (Loss)	-652,247	-458,822	-1,197,555	-263,381	'	'	'	'	-208,331	'
Working Capital Deficit	'	'	1,680,000	'	'	'	'	'	'	'
Total stockholders' equity (deficiency)	95,041	'	95,041	'	314,180	'	'	'	'	'
Net income (loss)	-676,333	-475,434	-1,265,836	-351,148	'	'	'	'	'	'
Net cash provided by operating activities	'	'	-314,912	-149,409	'	'	'	'	'	'
Taxes Payable	'	'	'	'	'	'	'	'	700,000	'
Payments to Acquire Loans Receivable	'	'	'	'	'	'	'	'	1,009,115	'
Capital Lease Obligations	'	'	'	'	'	'	'	'	50,000	'
Delinquent Payroll And Tax Taxes Monthly Payments	'	'	'	'	'	'	'	35,000	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	'	'	'	279,333	50,000	'	'	'
Registered Public Offering Funding Amount	'	'	'	'	'	'	'	'	'	$750,000
Registered Public Offering Funding Percentage	'	'	'	'	'	'	'	'	'	5.00%

Summary_of_Significant_Account3

Summary of Significant Accounting Polices (Details) (Customer A [Member])	Mar. 31, 2014		Jun. 30, 2013
Customer A [Member]	'		'
Concentration Risk [Line Items]	'		'
Percentage Of Accounts Receivable Concentration	'	[1]	11.00%
[1]	Less than 10%

Summary_of_Significant_Account4

Summary of Significant Accounting Polices (Details 1)	3 Months Ended				9 Months Ended
	Mar. 31, 2014		Mar. 31, 2013		Mar. 31, 2014		Mar. 31, 2013
Customer A [Member]	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
Percentage Of Customer Revenue Concentration	'	[1]	'	[1]	13.00%		12.00%
Customer B [Member]	'		'		'		'
Concentration Risk [Line Items]	'		'		'		'
Percentage Of Customer Revenue Concentration	'	[1]	16.00%		'	[1]	11.00%
[1]	Less than 10%

Summary_of_Significant_Account5

Summary of Significant Accounting Polices (Details 2)	3 Months Ended				9 Months Ended
	Mar. 31, 2014		Mar. 31, 2013		Mar. 31, 2014	Mar. 31, 2013
Vendor A [Member]	'		'		'	'
Concentration Risk [Line Items]	'		'		'	'
Concentration Risk, Percentage	18.00%		13.00%		23.00%	19.00%
Vendor B [Member]	'		'		'	'
Concentration Risk [Line Items]	'		'		'	'
Concentration Risk, Percentage	11.00%		14.00%		11.00%	'	[1]
Vendor C [Member]	'		'		'	'
Concentration Risk [Line Items]	'		'		'	'
Concentration Risk, Percentage	'	[1]	'	[1]	11.00%	'	[1]
[1]	Less than 10%

Summary_of_Significant_Account6

Summary of Significant Accounting Policies (Details 3)	9 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013	Jun. 30, 2012
Euro To US Dollar [Member]	'	'	'	'
Period end exchange rate	1.38	1.28	1.3	1.26
Average period exchange rate	1.35	1.29	1.29	1.34
Mexian Peso To US Dollar [Member]	'	'	'	'
Period end exchange rate	0.08	0.08	0.08	0.08
Average period exchange rate	0.08	0.08	0.08	0.08

Summary_of_Significant_Account7

Summary of Significant Accounting Polices (Details 4) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Numerator:	'	'	'	'
Net income (loss)	($676,333)	($475,434)	($1,265,836)	($351,148)
Denominator:	'	'	'	'
Weighted average shares outstanding (basic)	17,392,213	17,254,551	17,176,541	17,181,559
Effect of diluted securities	0	0	0	0
Weighted average shares outstanding (diluted)	17,392,213	17,254,551	17,176,541	17,181,559
Net income (loss) per share:	'	'	'	'
Basic	($0.04)	($0.03)	($0.07)	($0.02)
Diluted	($0.04)	($0.03)	($0.07)	($0.02)

Summary_of_Significant_Account8

Summary of Significant Accounting Policies (Details Textual) (USD $)	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Jun. 30, 2013
		Employee Stock Option [Member]	Employee Stock Option [Member]	Warrant [Member]	Warrant [Member]	Europe Financial Institutions [Member]	Europe Financial Institutions [Member]
Summary of Significant Accounting Policies [Line Items]	'	'	'	'	'	'	'
Cash, Fdic Insured Amount	$250,000	'	'	'	'	'	'
Deposits	'	'	'	'	'	$191,349	$393,093
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	'	1,885,437	1,680,898	907,998	2,376,173	'	'

Line_of_Credit_Details_Textual

Line of Credit (Details Textual) (USD $)	9 Months Ended		9 Months Ended	1 Months Ended	9 Months Ended
	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Jul. 23, 2010	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
			Taag [Member]	Silicon Valley Bank [Member]	Silicon Valley Bank [Member]	Silicon Valley Bank [Member]	Silicon Valley Bank [Member]
			Maximum [Member]			Through June Thirty Twenty Fourty [Member]	Thereafter [Member]
Line of Credit Facility [Line Items]	'	'	'	'	'	'	'
Line of Credit Facility, Amount Outstanding	'	'	'	$4,000,000	'	'	$50,000
Line Of Credit Facility Expiration Date 1	'	'	'	'	31-Mar-14	'	'
Line Of Credit Facility Spread On Interest Rate	'	'	'	'	2.50%	'	'
Line Of Credit Facility Minimum Amount Outstanding	800,000	'	'	'	'	'	'
Line of Credit Facility, Interest Rate Description	'the prime rate plus 5.25%	'	'	'	'	'	'
Line of Credit Facility, Remaining Borrowing Capacity	2,116,000	2,000,000	'	'	'	'	'
Line of Credit Facility, Interest Rate at Period End	6.50%	'	'	'	'	'	'
Percentage Of Eligible Accounts Receivable On Line Of Credit	'	'	'	80.00%	'	'	'
Debt Instrument, Covenant Description	'	'	'	'	'Financial covenants are measured on North American operations only and include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $500,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2013, plus 50% of the dollar value of equity issuances after October 1, 2013 (reduced to 40% of the dollar value of equity issuances in connection with the exercise of warrants in November 2013) and the principal amount of subordinated debt.	'	'
Debt Instrument, Covenant Compliance	'	'	'	'	'The Company failed to comply with the tangible net worth covenant in December 2011 and July 2013. On both occasions the parties agreed to amend and reset the minimum tangible net worth required under the covenant.	'	'
Line of Credit Facility, Maximum Borrowing Capacity	'	'	'	'	'	279,333	50,000
Registered Public Offering Funding Amount	'	'	$750,000	'	'	'	'
Registered Public Offering Funding Percentage	'	'	5.00%	'	'	'	'

Factor_Agreements_Details_Text

Factor Agreements (Details Textual)	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2014	Jun. 30, 2013	Mar. 31, 2014	Jun. 30, 2013
	USD ($)	USD ($)	Abn [Member]	Abn [Member]	Credit Cooperatif [Member]	Credit Cooperatif [Member]	Credit Cooperatif [Member]	Natixis [Member]	Natixis [Member]
			USD ($)	USD ($)	USD ($)	EUR (€)	USD ($)	USD ($)	USD ($)
Factor Agreements [Line Items]	'	'	'	'	'	'	'	'	'
Factor Arrangements Maximum Limit	'	'	'	'	$325,000	€ 250,000	'	'	'
Factor Interest Rate Spread	'	'	'	'	'	'	'	1.60%	'
Factor Interest Rate Percentage Year End	0.45%	'	'	'	5.00%	5.00%	'	1.80%	'
Due From Factor Current	'	'	0	165,971	'	'	'	'	'
Due To Factor Current	$63,245	$246,221	'	'	$0	'	$246,221	$63,245	$0

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	9 Months Ended
	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding beginning balance, Shares	1,692,898
Granted, Shares	192,539
Options vesting, Shares	0
Exercised, Shares	0
Forfeited/Cancelled, Shares	0
Outstanding ending balance, Shares	1,885,437
Outstanding beginning balance, Weighted Average Exercise Price	$1.24
Granted, Weighted Average Exercise Price	$1.80
Options vesting, Weighted Average Exercise Price	$0
Exercised, Weighted Average Exercise Price	$0
Forfeited/Cancelled, Weighted Average Exercise Price	$0
Outstanding ending balance, Weighted Average Exercise Price	$1.30
Unvested [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding beginning balance, Shares	340,168
Granted, Shares	185,139
Options vesting, Shares	-147,084
Exercised, Shares	0
Forfeited/Cancelled, Shares	0
Outstanding ending balance, Shares	378,223
Outstanding beginning balance, Weighted Average Exercise Price	$1.29
Granted, Weighted Average Exercise Price	$1.80
Options vesting, Weighted Average Exercise Price	$1.28
Exercised, Weighted Average Exercise Price	$0
Forfeited/Cancelled, Weighted Average Exercise Price	$0
Outstanding ending balance, Weighted Average Exercise Price	$1.54
Vested [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding beginning balance, Shares	1,352,730
Granted, Shares	7,400
Options vesting, Shares	147,084
Exercised, Shares	0
Forfeited/Cancelled, Shares	0
Outstanding ending balance, Shares	1,507,214
Outstanding beginning balance, Weighted Average Exercise Price	$1.23
Granted, Weighted Average Exercise Price	$1.80
Options vesting, Weighted Average Exercise Price	$1.28
Exercised, Weighted Average Exercise Price	$0
Forfeited/Cancelled, Weighted Average Exercise Price	$0
Outstanding ending balance, Weighted Average Exercise Price	$1.24

Stockholders_Equity_Details_1

Stockholders' Equity (Details 1) (Stock Options [Member], USD $)	9 Months Ended
	Mar. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Options Outstanding	1,885,437
Options Exercisable	1,507,214
Range One [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1
Options Outstanding	347,000
Remaining Contractual Life (in years)	'5 years 1 month 28 days
Options Exercisable	347,000
Range Two [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.02
Options Outstanding	287,000
Remaining Contractual Life (in years)	'6 years 3 months 29 days
Options Exercisable	287,000
Range Three [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.07
Options Outstanding	53,898
Remaining Contractual Life (in years)	'8 years 6 months 18 days
Options Exercisable	43,898
Range Four [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.15
Options Outstanding	278,000
Remaining Contractual Life (in years)	'8 years 10 months 10 days
Options Exercisable	203,333
Range Five [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.25
Options Outstanding	32,000
Remaining Contractual Life (in years)	'8 years 10 months 17 days
Options Exercisable	13,333
Range Six [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.30
Options Outstanding	263,000
Remaining Contractual Life (in years)	'7 years 11 months 5 days
Options Exercisable	197,250
Range Seven [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.50
Options Outstanding	380,000
Remaining Contractual Life (in years)	'3 years 9 months 22 days
Options Exercisable	380,000
Range Eight [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.75
Options Outstanding	1,067
Remaining Contractual Life (in years)	'9 years 10 months 2 days
Options Exercisable	0
Range Nine [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.80
Options Outstanding	190,050
Remaining Contractual Life (in years)	'9 years 5 months 23 days
Options Exercisable	7,400
Range Ten [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.85
Options Outstanding	24,000
Remaining Contractual Life (in years)	'9 years 1 month 20 days
Options Exercisable	0
Range Eleven [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$1.97
Options Outstanding	1,422
Remaining Contractual Life (in years)	'9 years 7 months 24 days
Options Exercisable	0
Range Twelve [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$3
Options Outstanding	15,000
Remaining Contractual Life (in years)	'6 years 9 months 14 days
Options Exercisable	15,000
RangeThirteenMember [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$3.05
Options Outstanding	10,000
Remaining Contractual Life (in years)	'6 years 10 months 13 days
Options Exercisable	10,000
Range Fourteen [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Option Exercise Price	$3.65
Options Outstanding	3,000
Remaining Contractual Life (in years)	'6 years 11 months 23 days
Options Exercisable	3,000

Stockholders_Equity_Details_2

Stockholders' Equity (Details 2) (Warrant [Member], USD $)	9 Months Ended
	Mar. 31, 2014
Warrant [Member]	'
Outstanding, Beginning balance Number of Warrants	2,376,173
Granted, Number of Warrants	0
Exercised, Number of Warrants	-419,000
Expired, Number of Warrants	-1,052,175
Outstanding, Ending balance Number of Warrants	904,998
Exercisable, June 30, 2013 Number of Warrants	2,376,173
Exercisable, March 31, 2014 Number of Warrants	904,998
Outstanding, Beginning balance Weighted Average Exercise Price	$2.06
Granted, Weighted Average Exercise Price	$0
Exercised, Weighted Average Exercise Price	$2
Expired, Weighted Average Expired Price	$2.37
Outstanding, Ending balance Weighted Average Exercise Price	$1.73
Exercisable, June 30, 2013 Weighted Average Exercise Price	$2.06
Exercisable, March 31, 2014 Weighted Average Exercise Price	$1.73

Stockholders_Equity_Details_3

Stockholders' Equity (Details 3) (Warrant [Member], USD $)	9 Months Ended
	Mar. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Outstanding	904,998
Warrant Exercisable	904,998
Range One [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Exercise Price	$1.19
Warrant Outstanding	150,000
Remaining Contractual Life (in years)	'7 years 8 months 23 days
Warrant Exercisable	150,000
Range Two [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Exercise Price	$1.25
Warrant Outstanding	150,000
Remaining Contractual Life (in years)	'1 year 7 months 6 days
Warrant Exercisable	150,000
Range Three [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Exercise Price	$1.75
Warrant Outstanding	333,331
Remaining Contractual Life (in years)	'7 months 20 days
Warrant Exercisable	333,331
Range Four [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Exercise Price	$2.25
Warrant Outstanding	266,667
Remaining Contractual Life (in years)	'8 months 23 days
Warrant Exercisable	266,667
Range Five [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Exercise Price	$3.50
Warrant Outstanding	2,500
Remaining Contractual Life (in years)	'2 years 3 months
Warrant Exercisable	2,500
Range Six [Member]	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Warrant Exercise Price	$4
Warrant Outstanding	2,500
Remaining Contractual Life (in years)	'2 years 3 months
Warrant Exercisable	2,500

Stockholders_Equity_Details_4

Stockholders' Equity (Details 4) (USD $)	9 Months Ended
	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number Of Non-vested Shares, Beginning Balane ( in shares)	33,939
Granted, Number Of Shares	171,951
Vested, Number Of Shares	0
Forfeited, Number Of Shares	0
Number Of Non-vested Shares, Ending Balance (in shares)	205,890
Non-vested, Beginning Balance Weighted Average Grant date Fair Value	$1.85
Granted Weighted Average Grant date Fair Value	$1.81
Vested Weighted Average Grant date Fair Value	$0
Forfeited Weighted Average Grant date Fair Value	$0
Non-vested,Ending Balance Weighted Average Grant date Fair Value	$1.82

Stockholders_Equity_Details_Te

Stockholders' Equity (Details Textual) (USD $)

0 Months Ended

1 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

Sep. 06, 2013

Jan. 28, 2014

Nov. 22, 2013

Nov. 30, 2013

Mar. 31, 2014

Mar. 31, 2013

Sep. 06, 2013

Jan. 28, 2014

Mar. 31, 2014

Nov. 15, 2012

Nov. 15, 2012

Dec. 06, 2013

Mar. 31, 2014

Nov. 30, 2013

Mar. 31, 2014

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Minimum [Member]

Maximum [Member]

Consultant Services [Member]

Warrant [Member]

Common Stock [Member]

Common Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant

'

'

'

'

823,339

'

'

'

'

1,500,000

3,000,000

'

'

'

'

Share Based Compensation Warrants Fair Value

'

'

'

'

'

'

'

'

'

'

'

'

$304,666

'

'

Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2

'

'

'

'

'6 years 8 months 5 days

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term

'

'

'

'

'6 years 4 months 6 days

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value

'

'

'

'

1,317,556

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value

'

'

'

'

1,180,409

'

'

'

'

'

'

'

'

'

'

Fair value of vested stock options

'

'

'

'

188,380

267,501

'

'

'

'

'

'

'

'

'

Unallocated Share Based Compensation

'

'

'

'

352,370

'

'

'

'

'

'

'

'

'

'

Shares Issued During Period Share Exercise Of Warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

419,000

419,000

Shares Issued During Period Value Exercise Of Warrants

'

'

'

838,000

838,000

'

'

'

'

'

'

'

'

'

419

Stock Issued During Period, Shares, Employee Stock Ownership Plan

'

'

'

'

'

'

150,833

9,435

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total

271,499

16,511

'

'

'

'

'

'

'

'

'

'

'

'

'

Restricted Stock Issued Price Per Share

$1.80

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Restricted Stock Award, Gross

'

'

11,683

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Restricted Stock Award, Gross

'

'

23,016

'

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value

'

'

'

'

'

'

'

'

73,087

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options

'

'

'

'

'

'

'

'

237,939

'

'

'

'

'

'

Common Stock Market Price Per Share

'

$1.75

$1.97

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, Issued For Services

'

'

'

'

'

'

'

'

'

'

'

2,748

'

'

174,699

Stock Issued During Period, Value, Issued For Services

'

'

'

'

$78,308

'

'

'

'

'

'

$5,222

'

'

$175

Geographical_Information_Detai

Geographical Information (Details) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2013
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenue	$8,642,184	$10,646,757	$26,842,284	$34,170,854	'
Cost of revenue	6,585,690	8,387,352	20,560,508	26,995,904	'
Selling, general and administrative expenses	2,581,599	2,355,007	7,113,874	6,760,418	'
Depreciation and amortization	127,142	140,335	365,457	461,907	'
Loss On Facility Sublease	0	233,015	0	233,015	'
Gain on sale of fixed assets	0	-10,130	0	-17,009	'
Income (loss) from operations	-652,247	-458,822	-1,197,555	-263,381	'
Current assets	8,179,769	'	8,179,769	'	7,683,723
Property and equipment, net	613,293	'	613,293	'	831,231
Intangible assets, net	82,617	'	82,617	'	123,482
Other non-current assets	296,412	'	296,412	'	286,073
Total assets	9,172,091	'	9,172,091	'	8,924,509
Current liabilities	8,879,918	'	8,879,918	'	8,106,225
Long term liabilities	197,132	'	197,132	'	504,104
Equity	95,041	'	95,041	'	314,180
Total liabilities and equity	9,172,091	'	9,172,091	'	8,924,509
North American Operations [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenue	6,791,278	7,878,181	20,791,856	26,525,404	'
Cost of revenue	5,392,784	6,714,629	16,880,209	22,399,973	'
Selling, general and administrative expenses	1,788,319	1,387,339	4,746,191	3,752,936	'
Depreciation and amortization	56,359	47,857	154,680	185,324	'
Loss On Facility Sublease	'	233,015	'	233,015	'
Gain on sale of fixed assets	'	0	'	-18,630	'
Income (loss) from operations	-446,184	-504,659	-989,224	-27,214	'
Current assets	6,617,095	'	6,617,095	'	5,536,474
Property and equipment, net	120,818	'	120,818	'	189,596
Intangible assets, net	82,617	'	82,617	'	123,482
Other non-current assets	9,698	'	9,698	'	9,712
Total assets	6,830,228	'	6,830,228	'	5,859,264
Current liabilities	5,637,413	'	5,637,413	'	4,732,746
Long term liabilities	0	'	0	'	0
Equity	1,192,815	'	1,192,815	'	1,126,518
Total liabilities and equity	6,830,228	'	6,830,228	'	5,859,264
TAAG [Member]	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'
Revenue	1,850,906	2,768,576	6,050,428	7,645,450	'
Cost of revenue	1,192,906	1,672,723	3,680,299	4,595,931	'
Selling, general and administrative expenses	793,280	967,668	2,367,683	3,007,482	'
Depreciation and amortization	70,783	92,478	210,777	276,583	'
Loss On Facility Sublease	'	0	'	0	'
Gain on sale of fixed assets	'	-10,130	'	1,621	'
Income (loss) from operations	-206,063	45,837	-208,331	-236,167	'
Current assets	1,562,674	'	1,562,674	'	2,147,249
Property and equipment, net	492,475	'	492,475	'	641,635
Intangible assets, net	0	'	0	'	0
Other non-current assets	286,714	'	286,714	'	276,361
Total assets	2,341,863	'	2,341,863	'	3,065,245
Current liabilities	3,242,505	'	3,242,505	'	3,373,479
Long term liabilities	197,132	'	197,132	'	504,104
Equity	-1,097,774	'	-1,097,774	'	-812,338
Total liabilities and equity	$2,341,863	'	$2,341,863	'	$3,065,245